Interleukin-4 polymorphism is associated with severity of respiratory syncytial virus infection

Mingzhi Zhang1, Yong Lu1, Xiaobo Zhang1

  • 1Pulmonology Department, Children's Hospital of Fudan University, Shanghai, China.

Insights

Interleukin-4 (IL-4) gene polymorphisms, specifically -590C/T and -33C/T, are linked to respiratory syncytial virus (RSV) infection susceptibility and severity in Chinese children. These genetic variations influence how likely children are to contract RSV and how severe their illness becomes.

Area of Science:

  • Genetics and Immunology
  • Pediatric Infectious Diseases
  • Molecular Biology

Background:

  • Respiratory syncytial virus (RSV) is a significant pediatric respiratory pathogen.
  • Interleukin-4 (IL-4) plays a crucial role in immune responses.
  • Genetic variations in IL-4 may influence susceptibility and severity of RSV infections.

Purpose of the Study:

  • To investigate the association between IL-4 gene polymorphisms (-590C/T and -33 C/T) and RSV infection susceptibility in Chinese Han children.
  • To determine if these IL-4 polymorphisms correlate with the severity of RSV bronchiolitis.

Main Methods:

  • Case-control study involving 218 children with RSV bronchiolitis and 303 healthy controls.
  • Genotyping of IL-4 -590C/T and -33 C/T single nucleotide polymorphisms (SNPs).
  • Assessment of RSV bronchiolitis severity using a standardized respiratory scoring system.

Main Results:

  • Significant differences in the frequencies of IL-4 -590C/T and -33 C/T polymorphisms were observed between RSV patients and controls.
  • The T-T haplotype (-590 and -33) showed a significant difference in frequency between groups.
  • Patients with IL-4 -590TT and -33TT genotypes exhibited higher respiratory scores, indicating increased infection severity.

Conclusions:

  • IL-4 -590C/T and -33 C/T polymorphisms are associated with both susceptibility to and severity of RSV infection in Chinese Han children.
  • These genetic markers may serve as potential indicators for RSV risk and disease progression.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69